MUSL

Promino secures first U.S. grocery order for Rejuvenate at 20 Kansas City stores.

Promino secures US$5 million minimum sales commitment through new global social commerce deal.

Promino lands Kroger test, but financial impact and future sales remain unproven.

Big retail wins, but no proof yet these deals will drive real sales or profits.

Promino shows distribution growth, but lacks proof of sustainable profits or financial momentum.

Promino is selling hope, not results—no hard data, just plans and promises.

This is a straightforward debt restructuring, not a growth or operational milestone.

This is a branding move with little hard evidence or near-term financial impact for investors.

Promino is selling hype, not results—no financials, just marketing and athlete endorsements.

Big promises, but almost no hard numbers—watch, don’t buy, until results are proven.

Promino raised cash, but offers no proof of business traction or operational progress.

This is a routine financing update with minimal insight into business fundamentals or growth.

Celebrity deals grab headlines, but hard numbers are missing and real progress is unproven.

This is a plain vanilla financing with minimal disclosure and no operational transparency.

Promino touts product buzz and a small financing, but hard numbers are missing.

Promino’s turnaround is real, but details are thin and risks remain for investors.

This is a bare-bones capital raise announcement with no evidence of actual progress yet.